Eurobio Financial Statements From 2010 to 2024
| ALERS Stock | 25.60 0.05 0.19% |
Check Eurobio Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eurobio Scientific's main balance sheet or income statement drivers, such as , as well as many indicators such as . Eurobio financial statements analysis is a perfect complement when working with Eurobio Scientific Valuation or Volatility modules.
Eurobio |
Eurobio Scientific SA Company Current Valuation Analysis
Eurobio Scientific's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Eurobio Scientific Current Valuation | 124.11 M |
Most of Eurobio Scientific's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eurobio Scientific SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Eurobio Scientific SA has a Current Valuation of 124.11 M. This is 99.14% lower than that of the Healthcare sector and 99.0% lower than that of the Medical Devices industry. The current valuation for all France stocks is 99.25% higher than that of the company.
Eurobio Scientific Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Eurobio Scientific's current stock value. Our valuation model uses many indicators to compare Eurobio Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eurobio Scientific competition to find correlations between indicators driving Eurobio Scientific's intrinsic value. More Info.Eurobio Scientific SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.51 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Eurobio Scientific SA is roughly 1.97 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eurobio Scientific's earnings, one of the primary drivers of an investment's value.About Eurobio Scientific Financial Statements
Eurobio Scientific shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Eurobio Scientific investors may analyze each financial statement separately, they are all interrelated. The changes in Eurobio Scientific's assets and liabilities, for example, are also reflected in the revenues and expenses on on Eurobio Scientific's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Eurobio Stock Analysis
When running Eurobio Scientific's price analysis, check to measure Eurobio Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eurobio Scientific is operating at the current time. Most of Eurobio Scientific's value examination focuses on studying past and present price action to predict the probability of Eurobio Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eurobio Scientific's price. Additionally, you may evaluate how the addition of Eurobio Scientific to your portfolios can decrease your overall portfolio volatility.